Abstract
Our understanding of the endothelium as an important moderator of vascular function has evolved significantly over the last several decades. Initially viewed as an inert interface between circulating blood and the vessel wall, we now acknowledge its complex and central role in the regulation of vascular tone, inflammation, homeostasis, permeability, and proliferation. Healthy endothelium is vital for maintenance of normal vascular function, balancing vasodilatory and vasoconstrictive influences, maintaining an antithrombotic microenvironment, and mediating the flow of nutrient substances, blood cells, and diverse biologically active molecules across the monolayer. However, failure to adapt to physiological or pathological stimuli may activate aberrant compensatory mechanisms that alter the endothelial phenotype and promote endothelial dysfunction, a pro-thrombotic, pro-proliferative, proinflammatory, and pro-constrictive phenotype. In the presence of traditional or novel risk factors of atherosclerosis, endothelial function degenerates prior to the appearance of morphological vascular changes. This endothelial dysfunction is readily measured through both invasive and noninvasive means and is predictive of future risk of adverse cardiac events. Coupled with efforts to investigate the hemodynamic, biochemical, and molecular processes underlying long-term changes in endothelial properties, therapeutic strategies to alleviate endothelial dysfunction provide a promising pathway to guide future therapeutic interventions and reduce cardiovascular morbidity and mortality.
Similar content being viewed by others
Abbreviations
- Endothelium:
-
The endothelium is the thin monolayer of cells that lines the inner surface of the blood vessels forming an interface between circulating blood in the lumen and the rest of the vessel wall. The cells that form the endothelium are called endothelial cells.
- Endothelial Dysfunction:
-
Endothelial dysfunction is an alteration of the endovascular lining of the blood vessels in response to various stimuli that is characterized by a pro-thrombotic, proinflammatory, pro-constrictive, and pro-proliferative phenotype.
- Flow-Mediated Dilation:
-
Endothelial function is often quantified by flow-mediated dilation (FMD), which represents the endothelium-dependent relaxation of a conduit artery – typically the brachial artery – due to an increased blood flow. Brachial artery reactivity is frequently used in noninvasive ultrasonographic assessment of FMD that indicates endothelium-dependent response to shear stress.
References
Abeywardena MY et al (2002) Age- and hypertension-induced changes in abnormal contractions in rat aorta. J Cardiovasc Pharmacol 40:930–937
Adam E et al (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2:291–293
Addabbo F et al (2009) Mitochondria and reactive oxygen species. Hypertension 53:885–892
Ahmadi N et al (2008) Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score. J Cardiovasc Comput Tomogr 2:382–388
Ahmadi N et al (2009) Low fingertip temperature rebound measured by digital thermal monitoring strongly correlates with the presence and extent of coronary artery disease diagnosed by 64-slice multi-detector computed tomography. Int J Cardiovasc Imaging 25:725–738
Ahmadi N et al (2011) Reproducibility and variability of digital thermal monitoring of vascular reactivity. Clin Physiol Funct Imaging 31:422–428
Aird W (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158–173
Ajani UA et al (2004) Body mass index and mortality among US male physicians. Ann Epidemiol 14:731–739
Al Suwaidi J et al (2001) Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37:1523–1528
Alexanderson E et al (2010) Endothelial dysfunction in systemic lupus erythematosus: evaluation with 13N-ammonia PET. J Nucl Med 51:1927–1931
Ames PR et al (2009) Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome. Clin Rev Allergy Immunol 37:29–35
Anderson T, Charbonneau F (2007) Dyslipidemia and Endothelial Dysfunction: Pathophysiology and Therapy. In: Caterina RD, Libby P (eds) Endothelial dysfunctions and vascular disease. Blackwell, Malden 245–257
Anderson TJ et al (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26:1235–1241
Anderson TJ et al (2011) Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 123:163–169
Apovian CM et al (2008) Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler, Thromb Vasc Biol 28:1654–1659
Arnal JF et al (1999) Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 55:1078–1087
Arnold WP et al (1977) Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:3203–3207
Asahara T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Augustin HG et al (1994) Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays 16:901–906
Babar GS et al (2011) Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care 34:681–685
Bae SW et al (2003) Rapid increase in endothelial nitric oxide production by bradykinin is mediated by protein kinase A signaling pathway. Biochem Biophys Res Commun 306:981–987
Balletshofer BM et al (2000) Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101:1780–1784
Barton M (2011) The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte. Pharmacol Res 63:455–462
Becher MU et al (2010) Regeneration of the vascular compartment. Herz 35:342–351
Beckman JS et al (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620–1624
Behrendt D, Ganz P (2002) Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90:40L–48L
Beltowski J (2012) Leptin and the regulation of endothelial function in physiological and pathological conditions. Clin Exp Pharmacol Physiol 39:168–178
Benjamin EJ et al (2004) Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. [Erratum appears in Circulation, 2004 Jun 29;109(25):3256]. Circulation 109:613–619
Boger RH et al (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98:1842–1847
Bonetti PO et al (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler, Thromb Vasc Biol 23:168–175
Bonetti PO et al (2004) Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44:2137–2141
Boo YC et al (2002) Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am J Physiol – Heart Circ Physiol 283:H1819–H1828
Bradley JR et al (1994) The vascular endothelium in septic shock. J Infec 28:1–10
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Brunner H et al (2005) Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:233–246
Caballero AE et al (2003) The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metab: Clin Exp 52:173–180
Callera GE et al (2006) Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci 110:243–253
Calver A et al (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Inves 90:2548–2554
Campbell WB, Fleming I (2010) Epoxyeicosatrienoic acids and endothelium-dependent responses. Pflugers Archiv – Eur J Physiol 459:881–895
Caterina RD, Libby P (2007) Endothelial dysfunctions in vascular disease-II. Blackwell Futura, Malden
Celermajer DS et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115
Celermajer DS et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149–2155
Celermajer DS et al (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24:471–476
Celermajer DS et al (1996) Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 334:150–154
Ceriello A et al (2012) Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes 61:2993–2997
Chatterjee Adhikari M et al (2012) Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41:669–675
Chen K, Keaney JF Jr (2012) Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 14:476–483
Chung WB et al (2009) The brachial artery remodels to maintain local shear stress despite the presence of cardiovascular risk factors. Arterioscler, Thromb Vasc Biol 29:606–612
Cines DB et al (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527–3561
Clarkson P et al (1996) Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28:573–579
Cook PJ, Honeybourne D (1994) Chlamydia pneumoniae. J Antimicrob Chemother 34:859–873
Cosentino F, Katusic ZS (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91:139–144
Cosentino F et al (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25–28
Damani S et al (2012) Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med 4:126–133
Demiot C et al (2007) WISE 2005: chronic bed rest impairs microcirculatory endothelium in women. Am J Physiol – Heart Circ Physiol 293:H3159–H3164
Dharmashankar K, Widlansky ME (2010) Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12:448–455
Ding L, Zhang J (2012) Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells. Zhongguo Yao Li Xue Bao/Acta Pharm Sin 33:75–81
Dohi Y et al (1992) Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19:131–137
Donato AJ et al (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100:1659–1666
Doughan AK et al (2008) Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res 102:488–496
Doyle M et al (2003) The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson 5:475–485
Dresner A et al (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Investig 103:253–259
Dudzinski DM et al (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46:235–276
Egan KM et al (2004) COX-2-derived prostacyclin confers atheroprotection on female mice. Science 306:1954–1957
Egashira K et al (1996) Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res 79:331–335
Fabricant CG et al (1978) Virus-induced atherosclerosis. J Exp Med 148:335–340
Feinberg MW, Jain MK (2005) Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Med 47:169–186
Feron O et al (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Investig 103:897–905
Ferrari AU et al (2003) Invited review: aging and the cardiovascular system. J Appl Physiol 95:2591–2597
Flammer AJ et al (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126:753–767
Folsom AR et al (1998) Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 98:845–850
Fukai T (2009) Extracellular SOD and aged blood vessels. Am J Physiol – Heart Circ Physiol 297:H10–H12
Fukuda Y et al (2002) Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87:264–269
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Galle J et al (1995) Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals. Circulation 92:1582–1589
Garrido AM, Griendling KK (2009) NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302:148–158
Ghiadoni L et al (2001) Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens 19:547–551
Gimbrone MA Jr et al (1974) Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 60:673–684
Gogitidze Joy N et al (2010) Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. [Erratum appears in Diabetes Care, 2010 Sep;33(9):2129]. Diabetes Care 33:1529–1535
Gokce N et al (2005) Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 95:266–268
Golbidi S, Laher I (2013) Exercise and the aging endothelium. J Diabetes Res 2013:789607
Gordon JL et al (2008) Health behaviors and endothelial function. J Behav Med 31:5–21
Gori T et al (2008) Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 51:1953–1958
Gori T et al (2012) Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J 33:363–371
Greenstein AS et al (2009) Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119:1661–1670
Griendling KK et al (2000a) Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler, Thromb Vasc Biol 20:2175–2183
Griendling KK et al (2000b) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494–501
Gu P, Xu A (2013) Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord 14:49–58
Gul KM et al (2009) Digital thermal monitoring of vascular function: a novel tool to improve cardiovascular risk assessment. Vasc Med 14:143–148
Guthikonda S et al (2003) Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 107:416–421
Gvozdjakova A et al (1992) Effect of smoking on the oxidative processes of cardiomyocytes. Cardiology 81:81–84
Halcox JP et al (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106:653–658
Hamburg NM et al (2008) Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117:2467–2474
Hamburg NM et al (2011) Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension 57:390–396
Harrison DG, Gongora MC (2009) Oxidative stress and hypertension. Med Clin N Am 93:621–635
Hashimoto M et al (1998) The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 22:477–484
Hazel AL, Pedley TJ (2000) Vascular endothelial cells minimize the total force on their nuclei. Biophys J 78:47–54
Heistad DD et al (1984) Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 54:711–718
Heitzer T et al (1996a) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94:6–9
Heitzer T et al (1996b) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346–1353
Heitzer T et al (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers: evidence for a dysfunctional nitric oxide synthase. Circ Res 86:E36–E41
Herrera MD et al (2010) Endothelial dysfunction and aging: an update. Ageing Res Rev 9:142–152
Hess OM et al (1990) Potential role of coronary vasoconstriction in ischaemic heart disease: effect of exercise. Eur Heart J 11(Suppl B):58–64
Higashi Y et al (2000) A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study. J Am Coll Cardiol 35:284–291
Hill JM et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. [Reprint in Can J Cardiol. 2004 Aug;20 Suppl B:44B-48B; PMID: 15309205]. N Engl J Med 348:593–600
Hink U et al (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88:E14–E22
Hirsch L et al (2011) The impact of early compared to late morning hours on brachial endothelial function and long-term cardiovascular events in healthy subjects with no apparent coronary heart disease. Int J Cardiol 151:342–347
His W (1865) Die Häute und Höhlen des Körpers: Academisches Programm. In: Schwighauser (ed) Basel
Hoch NE et al (2009) Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol – Regul Integr Comp Physiol 296:R208–R216
Hoenig MR et al (2008) Decreased vascular repair and neovascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Curr Mol Med 8:754–767
Holmvang G et al (1999) Relation between coronary “steal” and contractile function at rest in collateral-dependent myocardium of humans with ischemic heart disease. Circulation 99:2510–2516
Hoshino S et al (2005) Cigarette smoke extract induces endothelial cell injury via JNK pathway. Biochem Biophys Res Commun 329:58–63
HPS-Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. [Summary for patients in Curr Cardiol Rep. 2002 Nov;4(6):486–7; PMID: 12379169]. Lancet 360:7–22
Huang PL (2003) Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep 5:473–480
Huang PL et al (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242
Huang AL et al (2007) Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler, Thromb Vasc Biol 27:2113–2119
Igic R, Behnia R (2003) Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 9:697–706
Ignarro LJ et al (1987) Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61:866–879
Inoguchi T et al (1994) Insulin’s effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369–E379
Inoue N et al (1995) Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler, Thromb Vasc Biol 15:1255–1261
Jaffe EA et al (1973) Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Investig 52:2757–2764
Jaimes EA et al (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler, Thromb Vasc Biol 24:1031–1036
Jayaraman S (2012) Epigenetic mechanisms of metabolic memory in diabetes. Circ Res 110:1039–1041
Joannides R et al (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319
Johnstone MT et al (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510–2516
Juonala M et al (2006) Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study. Hypertension 48:424–430
Juonala M et al (2008) Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. J Am Coll Cardiol 52:293–299
Jurva JW et al (2006) The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. J Am Coll Cardiol 48:588–589
Katusic ZS et al (2012) Vascular effects of prostacyclin: does activation of PPAR play a role? Trends Pharmacol Sci 33:559–564
Keating ST, El-Osta A (2012) Chromatin modifications associated with diabetes. J Cardiovasc Transl Res 5:399–412
Ketonen J et al (2010) Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74:1479–1487
Kim HJ et al (2000) The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic Biol Med 28:683–692
Kim JA et al (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113:1888–1904
Kiowski W et al (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 90:27–34
Kizhakekuttu TJ, Widlansky ME (2010) Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther 28:e20–e32
Kizhakekuttu TJ et al (2012) Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans. Arterioscler, Thromb Vasc Biol 32:2531–2539
Kluge MA et al (2013) Mitochondria and endothelial function. Circ Res 112:1171–1188
Kol A, Libby P (2007) Infections and vascular disease. In: Caterina RD, Libby P (eds) Endothelial dysfunctions and vascular disease. Blackwell, Malden
Kuhn FE et al (1991) Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol 68:1425–1430
Kuo CC et al (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci U S A 92:6911–6914
Kushner EJ et al (2009) Aging and endothelial progenitor cell telomere length in healthy men. Clin Chem Lab Med 47:47–50
Kuvin JT et al (2003) Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146:168–174
Laufs U et al (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135
Lawlor DA, Leon DA (2005) Association of body mass index and obesity measured in early childhood with risk of coronary heart disease and stroke in middle age: findings from the Aberdeen children of the 1950s prospective cohort study. Circulation 111:1891–1896
Lee M, Vanhoutte PM (2010) Inflammation and endothelial dysfunction with aging. In: Dauphinee SM, Karsan A (eds) Endothelial dysfunction and inflammation. Springer, Basel, pp 189–200
Lekakis J et al (1998) Effects of acute cigarette smoking on endothelium-dependent arterial dilatation in normal subjects. Am J Cardiol 81:1225–1228
Leopold JA (2013) The endothelium. In: Creager M et al (eds) Vascular medicine: a companion to Braunwald’s heart disease, 2nd edn. Elsevier Saunders, Philadelphia, pp 14–24
Levin ER (1996) Endothelins as cardiovascular peptides. Am J Nephrol 16:246–251
Li H, Forstermann U (2009) Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15:3133–3145
Li JM, Shah AM (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol – Regul Integr Comp Physiol 287:R1014–R1030
Li H et al (2003) Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 107:2348–2354
Li L et al (2011) Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51:169–187
Liao JK et al (1995) Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270:319–324
Lin KY et al (2002) Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987–992
Lind L et al (2011) Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 123:1545–1551
Lopez-Campistrous A et al (2008) Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension. Hypertension 51:412–419
Loyer X et al (2014) Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res 114:434–443
Ludmer PL et al (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315:1046–1051
Lukacs NW et al (1995) Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood 86:2767–2773
Lundman P et al (2001) A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 159:35–41
Magen E et al (2010) Potential link between C3a, C3b and endothelial progenitor cells in resistant hypertension. Am J Med Sci 339:415–419
Mancini GB et al (1996) Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. [Erratum appears in Circulation 1996 Sep 15;94(6):1490]. Circulation 94:258–265
Marchesi C et al (2009) Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 54:1384–1392
Martin T et al (1997) Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 27:1091–1097
Matheeussen V et al (2011) Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol Chem 392:189–198
Mather KJ et al (2001) Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37:1344–1350
Matoba T et al (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Investig 106:1521–1530
Matsubara J et al (2012) Decreased levels of endogenous plasma active glucagon like peptide-1 were correlated with endothelial dysfunction in patients with coronary risk factors. Circulation 126:A10901
Matsuda Y et al (1993) High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res 72:1103–1109
McIntyre TM et al (1997) Molecular mechanisms of early inflammation. Thromb Haemost 78:302–305
MICRO-HOPE-substudy (2000) Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. [Erratum appears in Lancet 2000 Sep 2;356(9232):860]. Lancet 355:253–259
Mitchell GF et al (2004) Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. [Erratum appears in Hypertension. 2005 Feb;45(2):e9]. Hypertension 44:134–139
Miyagawa K et al (2007) Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats. J Hypertens 25:415–421
Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012
Moncada S, Vane JR (1984) Prostacyclin and its clinical applications. Ann Clin Res 16:241–252
Monnier L et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687
Montezano AC, Touyz RM (2012) Reactive oxygen species and endothelial function–role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 110:87–94
Morrish NJ et al (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14–S21
Muhlestein JB et al (1996) Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555–1561
Mukherjee S et al (2001) Effects of oxidized low density lipoprotein on nitric oxide synthetase and protein kinase C activities in bovine endothelial cells. Cell Mol Biol 47:1051–1058
Mullen MJ et al (2000) Atorvastatin but not l-arginine improves endothelial function in type I diabetes mellitus: a double-blind study. J Am Coll Cardiol 36:410–416
Murdaca G et al (2012) Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 224:309–317
Muris DM et al (2013) Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance. Rev Endocr Metab Disord 14:29–38
Nabel EG et al (1988) Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77:43–52
Neunteufl T et al (2000) Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain. Am J Cardiol 86:207–210
Nishikawa T et al (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790
Nitenberg A et al (1993) Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017–1025
Nohria A et al (2006) Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol 101:545–548
Nystrom T et al (2004) Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol – Endocrinol Metab 287:E1209–E1215
Ossei-Gerning N et al (1997) Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 35:120–124
Palmer RM et al (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526
Panza JA et al (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323:22–27
Parker BA et al (2011) Heterogeneous vasodilator pathways underlie flow-mediated dilation in men and women. Am J Physiol – Heart Circ Physiol 301:H1118–H1126
Parkington HC et al (2004) Prostacyclin and endothelium-dependent hyperpolarization. Pharmacol Res 49:509–514
Pate M, Darmala V (2010) Endothelial cell biology: role in inflammatory response. Adv Clin Chem 52:109–130
Patti G et al (2005) Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 111:70–75
Petrie JR et al (1998) How reproducible is bilateral forearm plethysmography? Br J Clin Pharmacol 45:131–139
Pierce GL et al (2009) Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans. Circulation 119:1284–1292
Prasad A et al (1999) Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin. J Am Coll Cardiol 33:796–804
Prasad A et al (2000) Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 101:2349–2354
Prasad A et al (2002) Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106:184–190
Puranik R, Celermajer DS (2003) Smoking and endothelial function. Prog Cardiovasc Dis 45:443–458
Pyorala K et al (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). [Erratum appears in Diabetes Care 1997 Jun;20(6):1048]. Diabetes Care 20:614–620
Quyyumi AA, Patel RS (2010) Endothelial dysfunction and hypertension: cause or effect? Hypertension 55:1092–1094
Raitakari OT et al (1999a) Effect of Lp(a) on the early functional and structural changes of atherosclerosis. Arterioscler, Thromb Vasc Biol 19:990–995
Raitakari OT et al (1999b) Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 130:578–581
Raitakari M et al (2004) Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler, Thromb Vasc Biol 24:124–128
Read MA et al (1994) NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med 179:503–512
Reriani MK et al (2010) Endothelial function as a functional expression of cardiovascular risk factors. Biomark Med 4:351–360
Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50:266–272
Ridker PM et al (2005) C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352:20–28
Ridker PM et al (2009) Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 373:1175–1182
Rossi R et al (2004) Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol 44:1636–1640
Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822–H827
Rubinshtein R et al (2010) Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 31:1142–1148
Saikku P (1993) Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J 14(Suppl K):62–65
Sander M et al (1999) A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33:937–942
Sasaki S et al (2002) A low-calorie diet improves endothelium-dependent vasodilation in obese patients with essential hypertension. Am J Hypertens 15:302–309
Schachinger V et al (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906
Schiffrin EL, Touyz RM (1998) Vascular biology of endothelin. J Cardiovasc Pharmacol 32(Suppl 3):S2–S13
Schnabel RB et al (2011) Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 4:371–380
Schwann T (1847) Microscopal researches into the accordance in the structure and growth of animals and plants. Sydenham Society, London
Schwartz BG et al (2010) The endothelial cell in health and disease: its function, dysfunction, measurement and therapy. Int J Impot Res 22:77–90
Seals DR et al (2008) Habitual exercise and arterial aging. J Appl Physiol 105:1323–1332
Sedentary Behaviour Research N (2012) Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol, Nutr Metab 37:540–542
Shechter M et al (2009a) Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 134:52–58
Shechter M et al (2009b) Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 11:588–593
Shechter M et al (2014) Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease. Am J Cardiol 113:162–167
Shishehbor MH et al (2003) Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289:1675–1680
Shoelson SE et al (2006) Inflammation and insulin resistance. J Clin Investig 116:1793–1801
Soltesz P et al (2011) Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev 10:416–425
Sorensen KE et al (1994) Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Investig 93:50–55
Spieker LE et al (2003) ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humans. J Cardiovasc Pharmacol 42:315–318
Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301–314
Stamler JS et al (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898–1902
Steinberg D (1997) Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 95:1062–1071
Steinberg HO et al (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Investig 97:2601–2610
Steinberg HO et al (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Investig 100:1230–1239
Steinberg HO et al (2000) Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 49:1231–1238
Stewart KG et al (2000) Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension 35:1242–1247
Stroes E et al (1997) Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Investig 99:41–46
Suboc T et al (2013) Moderate obesity and endothelial dysfunction in humans: influence of gender and systemic inflammation. Physiol Rep 1:e00058
Sun D et al (2004) Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am J Physiol – Heart Circ Physiol 286:H2249–H2256
Suwaidi JA et al (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954
Tabet F et al (2014) HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun 5:3292
Tabit CE et al (2010) Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord 11:61–74
Taddei S et al (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274–279
Takahashi M et al (1990) Lipoproteins are inhibitors of endothelium-dependent relaxation of rabbit aorta. Am J Physiol 258:H1–H8
Takase B et al (1998) Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 82(1535–1539):A1537–A1538
Tanaka H et al (2000) Aging, habitual exercise, and dynamic arterial compliance. Circulation 102:1270–1275
Thijssen DH et al (2010) Impact of inactivity and exercise on the vasculature in humans. Eur J Appl Physiol 108:845–875
Thijssen DH et al (2011) Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol – Heart Circ Physiol 300:H2–H12
Thijssen DH et al (2012) Impact of exercise training on arterial wall thickness in humans. Clin Sci 122:311–322
Thom DH et al (1991) Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 11:547–551
Tokunaga O et al (1989) Atherosclerosis- and age-related multinucleated variant endothelial cells in primary culture from human aorta. Am J Pathol 135:967–976
Torsney E, Xu Q (2011) Resident vascular progenitor cells. J Mol Cell Cardiol 50:304–311
Tounian P et al (2001) Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358:1400–1404
Treasure CB et al (1992) Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res 71:776–781
Triggle CR, Ding H (2002) Endothelium-derived hyperpolarizing factor: is there a novel chemical mediator? Clin Exp Pharmacol Physiol 29:153–160
Tzemos N et al (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 104:511–514
UKPDS-Group (1998a) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ 317:713–720
UKPDS-Group (1998b) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. [Erratum appears in Lancet 1999 Aug 14;354(9178):602]. Lancet 352:837–853
Utz W et al (2005) Blood oxygen level-dependent MRI of tissue oxygenation: relation to endothelium-dependent and endothelium-independent blood flow changes. Arterioscler, Thromb Vasc Biol 25:1408–1413
Vallance P, Chan N (2001) Endothelial function and nitric oxide: clinical relevance. Heart 85:342–350
van der Toorn M et al (2009) Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells. Am J Physiol – Lung Cell Mol Physiol 297:L109–L114
van Etten RW et al (2002) Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arterioscler, Thromb Vasc Biol 22:799–804
Vayssier-Taussat M et al (2001) Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am J Physiol – Heart Circ Physiol 280:H1293–H1300
Vita JA (2011) Endothelial function. Circulation 124:e906–e912
Vita JA, Keaney JF Jr (2002) Endothelial function: a barometer for cardiovascular risk? Circulation 106:640–642
Vita JA et al (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491–497
Wang R (2009) Hydrogen sulfide: a new EDRF. Kidney Int 76:700–704
Wang J, Widlansky M (2012) Cytoskeleton, cytoskeletal interactions, and vascular endothelial function. Cell Health Cytoskelet 4:1–9
Wang J et al (2012) Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase. Arterioscler, Thromb Vasc Biol 32:712–720
Watts SW (2010) Endothelin receptors: what’s new and what do we need to know? Am J Physiol – Regul Integr Comp Physiol 298:R254–R260
Wenzel P et al (2008) Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 198:65–76
Widder JD et al (2009) Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54:338–344
Widlansky ME (2010) The danger of sedenterism: endothelium at risk. Am J Physiol – Heart Circ Physiol 299:H243–H244
Widlansky ME, Gutterman DD (2011) Regulation of endothelial function by mitochondrial reactive oxygen species. Antioxid Redox Signal 15:1517–1530
Widlansky ME et al (2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149–1160
Williams SB et al (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97:1695–1701
Wright RJ et al (2010) Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33:1591–1597
Xia P et al (1994) Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122–1129
Yanagisawa M et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Yeboah J et al (2007) Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 115:2390–2397
Yeboah J et al (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120:502–509
Yildiz O (2007) Vascular smooth muscle and endothelial functions in aging. Ann N Y Acad Sci 1100:353–360
Yoon HJ et al (2010) Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech Ageing Dev 131:119–123
Yoshizumi M et al (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73:205–209
Zeiher AM et al (1989) Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14:1181–1190
Zeiher AM et al (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401
Zeng ZH et al (2009) The functional changes of the perivascular adipose tissue in spontaneously hypertensive rats and the effects of atorvastatin therapy. Clin Exp Hypertens (NY) 31:355–363
Zhou Q, Liao JK (2010) Pleiotropic effects of statins – basic research and clinical perspectives. Circ J 74:818–826
Ziegler T et al (1998) Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32:351–355
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Widlansky, M.E., Malik, M.A. (2014). Vascular Endothelial Function. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37393-0_8-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-37393-0_8-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-37393-0
eBook Packages: Springer Reference MedicineReference Module Medicine